Axial spondyloarthritis

Latest

On the horizon: the TOPPIA consortium and chronic pain in inflammatory arthritis

On the horizon: the TOPPIA consortium and chronic pain in inflammatory arthritis

Transparent human figure with arms outstretched showing the skeletal system, with the spine highlighted in bright yellow and the lower back glowing red, indicating spinal pain or inflammation to illustrate the finding that upadacitinib delivers rapid and sustained pain relief across axSpA spectrum

Efficacy of upadacitinib for axSpA pain and outcomes assessed in post hoc analysis

Grayscale image of a woman seen from behind holding her neck

‘Male by default’ care model exposed in chronic neck and back pain guidelines

Middle aged woman sitting on a sofa and smiling while using a smartphone to illustrate robust evidence for the Axia app-based intervention in axial spondyloarthritis (axSpA)

Robust evidence for app-based intervention in axial spondyloarthritis

Six x-ray image illustrations showing a hand

National Early Inflammatory Autoimmune Diseases Audit: expert commentary

A 3d computer generated drawing of a human body in blue on a black background with a glowing spine and sacroiliac joints to suggest axial spondyloarthritis and illustrate a new BSR guideline

Axial spondyloarthritis guideline update: expert commentary

MHRA approves bimekizumab for psoriatic arthritis and axial spondyloarthritis

MHRA approves bimekizumab for psoriatic arthritis and axial spondyloarthritis

Long-term opioid use risk in one in three patients with rheumatic and MSK conditions

Long-term opioid use risk in one in three patients with rheumatic and MSK conditions

Higher malignancy risk with JAK inhibitors in rheumatology compared TNF inhibitors

Higher malignancy risk with JAK inhibitors in rheumatology compared TNF inhibitors

Two phase 3 trials find bimekizumab effective in both forms of axial spondyloarthritis

Two phase 3 trials find bimekizumab effective in both forms of axial spondyloarthritis